Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms

Intraductal papillary mucinous neoplasm (IPMN) can lead, via the adenoma-carcinoma sequence, to invasive adenocarcinoma, which has a poor prognosis. Most IPMNs do not meet the indications for surgery and instead are monitored regularly, but no biomarkers of malignant transformation during surveillan...

Full description

Saved in:
Bibliographic Details
Published inAnticancer research Vol. 41; no. 3; pp. 1663 - 1669
Main Authors SUGIMACHI, KEISHI, MANO, YOHEI, MATSUMOTO, YOSHIHIRO, NAKANOKO, TOMONORI, UEHARA, HIDEO, NAKASHIMA, YUICHIRO, SUGIYAMA, MASAHIKO, OTA, MITSUHIKO, MORITA, MASARU, TOH, YASUSHI
Format Journal Article
LanguageEnglish
Published Greece International Institute of Anticancer Research 01.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Intraductal papillary mucinous neoplasm (IPMN) can lead, via the adenoma-carcinoma sequence, to invasive adenocarcinoma, which has a poor prognosis. Most IPMNs do not meet the indications for surgery and instead are monitored regularly, but no biomarkers of malignant transformation during surveillance have been established. A total of 50 patients with IPMN who underwent pancreatectomy were evaluated retrospectively. Clinicopathological parameters during the surveillance period before surgery were assessed to explore biomarkers for predicting malignancy. The serum level of carbohydrate antigen 19-9 was significantly higher in IPMN-derived invasive adenocarcinoma. The neutrophil-to-lymphocyte ratio was significantly lower in low-grade IPMN than high-grade and Inv-IPMN cases by univariate and multivariate analysis. Disease-free survival was significantly shorter in patients with high-grade and invasive IPMN compared with those with low-grade IPMN. In patients whose preoperative surveillance was performed for more than 12 months, the neutrophil-to-lymphocyte ratio was significantly higher in those with high-grade and invasive IPMNs compared with patients with low-grade IPMN in the year before surgery. The NLR is a useful biomarker for distinguishing between low-grade and high-grade IPMN and thus should be monitored during surveillance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0250-7005
1791-7530
1791-7530
DOI:10.21873/anticanres.14929